 <h1>Epoprostenol Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of epoprostenol include:</b> agitation, anxiety, chest pain, headache, hypotension, nausea, nervousness, vomiting, and flushing. <b>Other side effects include:</b> abdominal pain, bradycardia, and dizziness.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to epoprostenol: intravenous powder for solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, epoprostenol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking epoprostenol:</p><p>
<i>More common</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>arm, back, or jaw pain</li>
<li>bladder pain</li>
<li>bleeding gums</li>
<li>bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>bloody or cloudy urine</li>
<li>blurred vision</li>
<li>changes in skin color</li>
<li>chest congestion</li>
<li>chest pain or discomfort</li>
<li>chest tightness or heaviness</li>
<li>chills</li>
<li>cold hands and feet</li>
<li>confusion</li>
<li>constipation</li>
<li>convulsions</li>
<li>cough or hoarseness</li>
<li>coughing up blood</li>
<li>decreased urine</li>
<li>depression</li>
<li>diarrhea</li>
<li>difficult, burning, or painful urination</li>
<li>difficulty with breathing or swallowing</li>
<li>dilated neck veins</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>dry mouth</li>
<li>extreme fatigue</li>
<li>fast, pounding, or irregular heartbeat or pulse</li>
<li>feeling of warmth</li>
<li>fever</li>
<li>headache</li>
<li>incoherent speech</li>
<li>increased menstrual flow or vaginal bleeding</li>
<li>increased thirst</li>
<li>increased urination</li>
<li>local infection at the catheter site</li>
<li>loss of appetite</li>
<li>metallic taste</li>
<li>muscle pain or cramps</li>
<li>muscle weakness</li>
<li>nausea or vomiting</li>
<li>nosebleeds</li>
<li>numbness or tingling in the hands, feet, or lips</li>
<li>pain at the injection site</li>
<li>pain, redness, or swelling in the arm or leg</li>
<li>paleness of the skin</li>
<li>prolonged bleeding from cuts</li>
<li>rapid weight gain</li>
<li>red or black, tarry stools</li>
<li>redness of the face, neck, arms, and occasionally, upper chest</li>
<li>sweating</li>
<li>swelling of the face, fingers, feet, or lower legs</li>
<li>tightness in the chest</li>
<li>tingling of the hands or feet</li>
<li>unusual tiredness or weakness</li>
<li>weight gain or loss</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Altered or abnormal touch sensation or sensitivity</li>
<li>blue lips and fingernails</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>coughing that sometimes produces a pink frothy sputum</li>
<li>difficult, fast, or noisy breathing</li>
<li>inability to speak</li>
<li>increased sweating</li>
<li>numbness or tingling in the hands, feet, or lips</li>
<li>pain or discomfort in the arms, jaw, back, or neck</li>
<li>seizures</li>
<li>severe or sudden headache</li>
<li>severe pain in the chest</li>
<li>slurred speech</li>
<li>sudden onset of severe breathing</li>
<li>temporary blindness</li>
<li>weakness in the arm or leg on one side of the body, sudden and severe</li>
<li>weakness or heaviness of the legs</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Feeling of fullness</li>
<li>high fever</li>
<li>pinpoint red spots on the skin</li>
<li>sensitivity to heat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>swollen glands</li>
<li>trouble sleeping</li>
<li>troubled breathing with exertion</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of epoprostenol may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Change in vision</li>
<li>difficulty having a bowel movement (stool)</li>
<li>difficulty with moving</li>
<li>heartburn</li>
<li>hives or welts</li>
<li>impaired vision</li>
<li>itching</li>
<li>joint pain</li>
<li>lack of appetite</li>
<li>lack or loss of strength</li>
<li>loss of interest or pleasure</li>
<li>muscle pains or stiffness</li>
<li>redness of the skin</li>
<li>shakiness in the legs, arms, hands, or feet</li>
<li>skin rash, encrusted, scaly and oozing</li>
<li>sores on the skin</li>
<li>swollen joints</li>
<li>tiredness</li>
<li>trembling or shaking of the hands or feet</li>
<li>trouble concentrating</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>belching</li>
<li>blurred vision or other changes in vision</li>
<li>excess air or gas in the stomach or intestines</li>
<li>indigestion</li>
<li>leg cramps</li>
<li>passing gas</li>
<li>sleepiness or unusual drowsiness</li>
<li>stomach discomfort or upset</li>
</ul><p>
<!-- end intravenous powder for solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to epoprostenol: intravenous powder for injection</i></p><h3>General</h3><p>The most frequently reported side effects during initiation and dose escalation were nausea, vomiting, headache, hypotension, flushing, chest pain, anxiety, dizziness, bradycardia, dyspnea, abdominal pain, musculoskeletal pain, and tachycardia.</p>
<p></p>
<p>The most frequently reported side effects during chronic dosing were jaw pain, headache, flushing, diarrhea, nausea, vomiting, flu-like symptoms, and anxiety/nervousness.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Palpitation (63%), flushing (up to 58%), cyanosis (up to 54%), tachycardia (up to 35%), pallor (up to 32%), hypotension (up to 27%), right heart failure (up to 25%), heart failure (23%)</p>
<p><b>Common</b> (1% to 10%): Bradycardia, myocardial infarction, shock, peripheral vascular disorder, vascular disorder</p>
<p><b>Postmarketing reports</b>: High output cardiac failure<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dizziness (up to 83%), headache (up to 83%), tremor (21%), hyperkinesia (up to 21%), syncope (up to 13%), hypesthesia (up to 12%), paresthesia (up to 12%), hyperesthesia (12%)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea/vomiting (up to 67%), esophageal reflux/gastritis (61%), diarrhea (up to 50%), ascites (up to 23%)</p>
<p><b>Common</b> (1% to 10%): Abdominal pain, dyspepsia, abdominal colic</p>
<p><b>Uncommon</b> (0.1% to 1%): Dry mouth<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Pain/neck pain/arthralgia (up to 84%), nonspecific musculoskeletal pain (up to 84%), jaw pain (up to 75%), myalgia (44%)</p>
<p><b>Common</b> (1% to 10%): Back pain, leg cramp</p>
<p><b>Frequency not reported</b>: Collagen disease<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Weight decreased (45%), pain (up to 29%), chills/fever/sepsis/flu-like symptoms (25%), fever (21%), hemorrhage/ hemorrhage injection</p>
<p>site/ hemorrhage rectal (11%), chest pain (11%)</p>
<p><b>Common</b> (1% to 10%): Asthenia, sepsis, septicemia, procedural complication</p>
<p><b>Very rare</b> (less than 0.01%): Lassitude</p>
<p><b>Frequency not reported</b>: Fatigue, edema, catheter-related infection<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Thrombocytopenia, bleeding</p>
<p><b>Postmarketing reports</b>: Anemia, hypersplenism, pancytopenia, splenomegaly<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Very rare</b> (less than 0.01%): Hyperthyroidism<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Hypoxia (up to 55%)</p>
<p><b>Common</b> (1% to 10%): Dyspnea, pneumothorax, hemothorax, cough increased, epistaxis, pharyngitis, pleural effusion, sinusitis, pulmonary edema, respiratory disorder</p>
<p><b>Postmarketing reports</b>: Pulmonary embolism<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Infection (18%), pain (up to 13%)</p>
<p><b>Very rare</b> (less than 0.01%): Erythema<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Anxiety/nervousness (up to 21%), depression (up to 13%), agitation (11%)</p>
<p><b>Common</b> (1% to 10%): Insomnia</p>
<p><b>Postmarketing reports</b>: Acute confusional state<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Skin ulcer (39%), eczema/rash/urticaria (up to 25%)</p>
<p><b>Common</b> (1% to 10%): Sweating, cellulitis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Hematuria, urinary tract infection<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Postmarketing reports</b>: Hepatic failure<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia (up to 66%)</p>
<p><b>Common</b> (1% to 10%): Hyperkalemia, hypercalcemia</p>
<p><b>Frequency not reported</b>: Blood glucose increased<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Epoprostenol Sodium (epoprostenol)." Teva Pharmaceuticals USA, North Wales, PA. </p><p id="ref_2">2. "Product Information. Flolan (epoprostenol)." Glaxo Wellcome, Research Triangle Park, NC. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_5">5. "Product Information. Veletri (epoprostenol)." Actelion Pharmaceuticals US Inc, South San Francisco, CA. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about epoprostenol</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>3 Reviews</li>
<li>Drug class: agents for pulmonary hypertension</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Epoprostenol Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Veletri, Flolan</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Pulmonary Hypertension</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to epoprostenol: intravenous powder for injection</i></p><h3>General</h3><p>The most frequently reported side effects during initiation and dose escalation were nausea, vomiting, headache, hypotension, flushing, chest pain, anxiety, dizziness, bradycardia, dyspnea, abdominal pain, musculoskeletal pain, and tachycardia.</p><p></p><p>The most frequently reported side effects during chronic dosing were jaw pain, headache, flushing, diarrhea, nausea, vomiting, flu-like symptoms, and anxiety/nervousness.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Palpitation (63%), flushing (up to 58%), cyanosis (up to 54%), tachycardia (up to 35%), pallor (up to 32%), hypotension (up to 27%), right heart failure (up to 25%), heart failure (23%)</p><p><b>Common</b> (1% to 10%): Bradycardia, myocardial infarction, shock, peripheral vascular disorder, vascular disorder</p><p><b>Postmarketing reports</b>: High output cardiac failure<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dizziness (up to 83%), headache (up to 83%), tremor (21%), hyperkinesia (up to 21%), syncope (up to 13%), hypesthesia (up to 12%), paresthesia (up to 12%), hyperesthesia (12%)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea/vomiting (up to 67%), esophageal reflux/gastritis (61%), diarrhea (up to 50%), ascites (up to 23%)</p><p><b>Common</b> (1% to 10%): Abdominal pain, dyspepsia, abdominal colic</p><p><b>Uncommon</b> (0.1% to 1%): Dry mouth<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Pain/neck pain/arthralgia (up to 84%), nonspecific musculoskeletal pain (up to 84%), jaw pain (up to 75%), myalgia (44%)</p><p><b>Common</b> (1% to 10%): Back pain, leg cramp</p><p><b>Frequency not reported</b>: Collagen disease<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Weight decreased (45%), pain (up to 29%), chills/fever/sepsis/flu-like symptoms (25%), fever (21%), hemorrhage/ hemorrhage injection</p><p>site/ hemorrhage rectal (11%), chest pain (11%)</p><p><b>Common</b> (1% to 10%): Asthenia, sepsis, septicemia, procedural complication</p><p><b>Very rare</b> (less than 0.01%): Lassitude</p><p><b>Frequency not reported</b>: Fatigue, edema, catheter-related infection<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Thrombocytopenia, bleeding</p><p><b>Postmarketing reports</b>: Anemia, hypersplenism, pancytopenia, splenomegaly<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Very rare</b> (less than 0.01%): Hyperthyroidism<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Hypoxia (up to 55%)</p><p><b>Common</b> (1% to 10%): Dyspnea, pneumothorax, hemothorax, cough increased, epistaxis, pharyngitis, pleural effusion, sinusitis, pulmonary edema, respiratory disorder</p><p><b>Postmarketing reports</b>: Pulmonary embolism<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Infection (18%), pain (up to 13%)</p><p><b>Very rare</b> (less than 0.01%): Erythema<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Anxiety/nervousness (up to 21%), depression (up to 13%), agitation (11%)</p><p><b>Common</b> (1% to 10%): Insomnia</p><p><b>Postmarketing reports</b>: Acute confusional state<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Skin ulcer (39%), eczema/rash/urticaria (up to 25%)</p><p><b>Common</b> (1% to 10%): Sweating, cellulitis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Hematuria, urinary tract infection<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Postmarketing reports</b>: Hepatic failure<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia (up to 66%)</p><p><b>Common</b> (1% to 10%): Hyperkalemia, hypercalcemia</p><p><b>Frequency not reported</b>: Blood glucose increased<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Epoprostenol Sodium (epoprostenol)." Teva Pharmaceuticals USA, North Wales, PA. </p><p id="ref_2">2. "Product Information. Flolan (epoprostenol)." Glaxo Wellcome, Research Triangle Park, NC. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_5">5. "Product Information. Veletri (epoprostenol)." Actelion Pharmaceuticals US Inc, South San Francisco, CA. </p><h2>More about epoprostenol</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>3 Reviews</li>
<li>Drug class: agents for pulmonary hypertension</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Epoprostenol Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Pulmonary Hypertension</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>